1. Market Research
  2. > Healthcare
  3. > Managed Care Market Trends
Europe E. coli Testing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; End User, and Country

Europe E. coli Testing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; End User, and Country

  • July 2020
  • 125 pages
  • ID: 5934802
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The Europe E. coli testing market is expected to reach US$ 726.5 million by 2027 from US$ 442.7 million in 2019. The market is estimated to grow at a CAGR of 6.5% during 2020-2027. The E. coli testing market is growing primarily due to the increasing E. coli testing, growing product innovation, and rising research activities in the Europe region that are boosting the market over the years. Factors such as E. coli testing challenges damages the growth of the market. Additionally, increasing adoption of multiplex PCR technology and developments in biotechnology sector are likely to fuel the growth of the E. coli testing market during the forecast period.

Escherichia coli (E. coli) are rod-shaped gram-negative bacteria that are generally available in the food, environment, and intestines of warm-blooded animals. The majority of the E. coli strains are typically harmless to humans. Still, some strains are recognized to be the reason for serious some medical complications such as gastrointestinal tract infections, cholecystitis, cholangitis, neonatal meningitis, bacteremia, pneumonia, urinary tract infection (UTI) and regularly spread via polluted food or water.

The rapid detection of pathogens in food is becoming increasingly critical for ensuring the safety of consumers, since the majority of food-borne illnesses and deaths are caused by pathogenic bacteria.Rapid, sensitive, inexpensive and convenient approaches to detect food-borne pathogenic bacteria is essential in controlling food safety.

The application of genetic-based techniques is able to detect the pathogenic bacteria with greater sensitivity and reliability than conventional culture methods.PCR is a promising method; it has been applied with success in various protocols used for pathogen detection, particularly multiplex PCR assay.

According to the European Centre for Disease Prevention and Control (ECDC), a contributing factor may be the shift from culture to culture-independent diagnostic methods, with PCR more commonly used to diagnose cases. For instance, Qiagen offers maricon for real time PCR screening for E. coli serotype and detection of E. coli serotype in food/animal feed. For instance, bioMérieux introduced GENE-UP, it is a new PCR-based molecular diagnostic system for the detection of microorganisms (bacteria and viruses). This platform enables the microbiological control of food, raw materials and the production environment for customers in the agri-food sector.

Multiplex PCR (mPCR) allows multiple gene analysis of bacteria at the same time in a single reaction tube simultaneously, saving time and reagents.A rapid, sensitive and specific method that would allow detection of multiple pathogens simultaneously from different types of foods would be very valuable for the food industry and regulatory agencies.

For instance, a mPCR system was developed for identification of entero- toxigenic Escherichia coli (ETEC) strains and to differentiate them from other gram-negative enteric bacteria. This increasing research activity and adoption of multiplex PCR in E. coli will boost the market growth in forecasted period.

The market for E. coli testing in Europe was well established before the outbreak of the COVID-19 pandemic. According to the latest ECDC-EFSA annual report on E. coli, European countries have reported higher incidences of West Nile virus and STEC infections in 2018. However, since early 2020, the outbreak of COVID-19 has resulted in the shifted focus of research centers and hospitals towards itself. In addition, various biotechnology companies in the European region have shifted their production for COVID-19 diagnostics. The shifted focus towards the COVID-19 diagnostic kits has hindered the E. coli testing market. It is expected that the growth is likely to have slower growth in coming next two-three years.

In 2019, the monoclonal antibodies segment accounted for the largest share of the E. coli testing market. Monoclonal antibodies offer advantages such as low cross-reactivity, high specificity, and excellent lot-to-lot stability, which are likely to contribute to the dominancy of the segment during the forecast period.

A few of the significant secondary sources associated with the Europe E. coli testing market report World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), and others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

North America E. coli Testing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; End User, and Country

  • $ 3000
  • July 2020
  • 125 pages

The North America E. coli testing market is expected to reach US$ 1,165.0 million by 2027 from US$ 680.9 Mn in 2019. The market is estimated to grow at a CAGR of 7.1% during 2020-2027. The E. coli testing ...

  • North America
  • Public Health
  • Monoclonal Antibody
  • Industry analysis
  • Hospital Revenue
  • Diagnostic Revenue


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on